FTXH : First Trust Nasdaq Pharmaceuticals ETF

FTXH is a Sector Equity Market Healthcare with MODERATE fees.

FTXH

First Trust Nasdaq Pharmaceuticals ETF

FI Score

42 /100

Diversification Rating

10 /10

Expense Ratio Rating

7 /10

Expense Rating

4 /10

Market Score

0 /10

Category Score

0 /10

Market Size

0 /10

42% FI Score
  • ftxh
  • ETF
  • Sector Equity
  • Healthcare

First Trust Nasdaq Pharmaceuticals ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.

Largest Holdings

Amount Holding
8.92% Eli Lilly and Company
8.41% Pfizer Inc
8.14% Johnson & Johnson
7.70% Zoetis Inc
7.44% Bristol-Myers Squibb Company
5.55% Catalent, Inc
5.45% Horizon Therapeutics Public Limited Company
4.53% Abbott Laboratories
4.16% Prestige Consumer Healthcare Inc
3.98% AbbVie Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo